Platelet inhibition and surgical bleeding: A plea for more science and evidence-based guidelines

Circulation Journal

Volumn 75, Issue 12, 2011, Pages 2751-2752

  Burcham, Pamela ^a   Blais, Danielle ^a   Firstenberg, Michael S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANGRELOR; CLOPIDOGREL; HEPARIN; PLACEBO; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOTTING PARAMETERS; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; HEART SURGERY; HUMAN; INDIVIDUALIZATION; ISCHEMIA; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PREOPERATIVE PERIOD; RECEPTOR BINDING; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FEMALE; HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; TICLOPIDINE;

EID: 82555186496     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1201     Document Type: Editorial

References (10)

1. Mariscalco G, Bruno VD, Cottini M, Borsani P, Banach M, Piffaretti G, et al. Optimal timing of discontinuation of clopidogrel and risk of blood transfusion after coronary surgery: Propensity score analysis. Circ J 2011; 75: 2805-2812
2. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, et al. Variability in individual responsiveness to clopidogrel. J Am Coll Cardiol 2007; 49: 1505-1516.
3. Ferraris VA, Ferraris SP, Saha SP, Hessel EA, Haan CK, Royston BD, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83: S27-S86.
4. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57: e215-e367.
5. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ. Executive Summary: American College of Chest Physicians evidencebased clinical practice guidelines. Chest 2008; 133: 71S-109S.
6. Nijjer SS, Watson G, Athanasiou T, Malik IS. Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: A meta-analysis of 34 studies. Eur Heart J 2011 [E-pub ahead of print].
7. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.
8. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-1616.
9. Banbury MK, Brizzio ME, Rajeswaran J, Lytle BW, Blackstone EH. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006; 202: 131-138.
10. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597-607.